Background Coronavirus disease-19 (COVID-19) can, in severe cases, lead to cytokine-
release syndrome owing to an excessive immune response. The release of different …

Background: Researchers have already reported a high level of interleukin (IL)-6 in patients
affected by Coronavirus Disease 2019 (COVID-19). In this study, we investigated the surge …

Objectives An excessive inflammatory response to SARS-CoV-2 is thought to be a major
cause of disease severity in COVID-19. The aim herein was to determine the prognostic …

Abstract Background: Interleukin-6 (IL-6) has been known to be involved in immune
regulation, inflammatory response, and metabolism. It is also recognized as the major cause …

Background accompanied to the spreading of coronavirus disease 2019 (Covid-19) in the
world, identifying factors related to the severity of the disease is one of the interests of …

Background and purpose Studies have shown that some cytokines in COVID‐19 patients
were elevated. This study aims to assess whether IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 …

The prognostic value of interleukin-6 in COVID-19 needs to be clarified. In this retrospective
study, COVID-19 patients treated in Renmin Hospital of Wuhan University from Jan 7 to Feb …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
alsoknownasthe2019novelCoronavirus (2019-nCoV), has caused a recent outbreak of …

Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …

Background. To investigate the association between interleukins (IL‐1β, IL‐2, IL‐4, IL‐6, IL‐
8, and IL‐10) and the disease severity of coronavirus disease 2019 (COVID‐19). Materials …